Goldman Laboratories Ltd
08945801
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Last accounts
28/03/2025
micro entity
Next accounts due
28/12/2026
Confirmation statement
Last: 13/02/2026
Due 27/02/2027
Industry
Officers
director · Since 18/03/2014
BIOMEDICAL ENGINEERING
FRENCH · UNITED KINGDOM · Age 44
Also on 1 other board
Persons with Significant Control
Mr Jordi Mascio
French · England · Age 44
Kemp House, City Road, London, EC1V 2NX
Notified 08/03/2017
Mr Diego Gianclaudio Rossi Mascio
British · United Kingdom · Age 41
Kemp House, 152 City Road, London, City Road, London, EC1V 2NX
Notified 01/02/2020
CompanyRankvs 10296+ SIC 32990 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 28/03/2026
Net Worth
-£102k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
-£127k
Working capital
Current Assets
£229k
Current Liabilities
£356k
Fixed Assets
£27k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 0.64 | -£113k |
| 2025 | 0.72 | -£171k |
| 2024 | 3.05 | -£11k |
| 2023 | 2.89 | — |
Derived from filed accounts. Not audited figures.